Drug Development Institute
Accelerating innovative research to speed cures to cancer patients
The Drug Development Institute (DDI) is a biotech-like institute embedded in The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). By bringing an industry-focused perspective to all investment and management decisions, the DDI ensures that programs have a high likelihood of progressing to clinical stage development. Our goal is to rapidly translate Ohio State’s most innovative research into tomorrow’s most promising treatments for patients with cancer.
The DDI employs a combination of targeted investments, strategic management and cutting-edge drug development resources to drive projects from discovery through early drug development, thus creating high-value new drug candidates.